![James Wassil](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Wassil
Verksamhetschef på
VAXCYTE, INC.
Förmögenhet: 9 M $ per 2026-08-31
Profil
Mr. James Wassil is a Chief Operating Officer & Executive Vice President at Vaxcyte, Inc. Mr. Wassil was previously employed as an Independent Director by Icosavax, Inc., a Vice President-Global Health & Value Business by Pfizer Inc., a Head-Global Product Development by Novartis AG, a Senior Director-International Marketing by Merck & Co., Inc., and a Member by Infectious Diseases Society of America.
He also served on the board at Icosavax, Inc. He received his undergraduate degree from the University of Notre Dame, a graduate degree from Lehigh University and an MBA from Lehigh University.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
VAXCYTE, INC. 0,1 % | 2026-10-05 | 145 435 ( 0,1 % ) | 9 M $ | 2026-08-31 |
Aktiva positioner av James Wassil
| Företag | Position | Start |
|---|---|---|
| VAXCYTE, INC. | Verksamhetschef | 2019-12-01 |
Tidigare kända positioner av James Wassil
| Företag | Position | Slut |
|---|---|---|
| ICOSAVAX, INC. | Direktör/Styrelseledamot | 2024-02-19 |
| ICOSAVAX, INC. | Direktör/Styrelseledamot | 2024-02-01 |
| PFIZER INC. | Företagsledare/Principal | 2019-12-01 |
| NOVARTIS AG | Företagsledare/Principal | 2015-05-01 |
| MERCK & CO., INC. | Försäljning & Marknadsföring | 2008-01-01 |
James Wassils utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
93
Första gradens relationer
8
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 8 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
University of Notre Dame
 University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Lehigh University
 Lehigh University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Infectious Diseases Society of America
 Infectious Diseases Society of America Miscellaneous Commercial ServicesCommercial Services Operates as a medical association representing physicians, scientists, and other healthcare professionals | Commercial Services |
Vaxcyte, Inc.
 Vaxcyte, Inc. BiotechnologyHealth Technology Develops vaccines for infectious diseases | Health Technology |
Icosavax, Inc.
 Icosavax, Inc. BiotechnologyHealth Technology Develops vaccines for infectious disease | Health Technology |
